Atlas Trials

Six-months Versus Nine-months ATT for Ocular TB

Clinical trial NCT06613919 · COMPLETED

Trial details

NCT number
NCT06613919
Sponsor
L.V. Prasad Eye Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Tuberculosis (TB)UveitisRetinal VasculitisChoroiditis
Start date
2020-01-01
Primary completion
2022-12-31
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.